Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 44 entries
Sorted by: Best Match Show Resources per page
ENAMEL-LIKE ANTIGENS IN HAGFISH: POSSIBLE EVOLUTIONARY SIGNIFICANCE.

Evolution; international journal of organic evolution

Slavkin HC, Graham E, Zeichner-David M, Hildemann W.
PMID: 28568376
Evolution. 1983 Mar;37(2):404-412. doi: 10.1111/j.1558-5646.1983.tb05548.x.

No abstract available.

Cite
Slavkin HC, Graham E, Zeichner-David M, et al. ENAMEL-LIKE ANTIGENS IN HAGFISH: POSSIBLE EVOLUTIONARY SIGNIFICANCE. Evolution. 1983;37(2):404-412doi: 10.1111/j.1558-5646.1983.tb05548.x.
Slavkin, H. C., Graham, E., Zeichner-David, M., & Hildemann, W. (1983). ENAMEL-LIKE ANTIGENS IN HAGFISH: POSSIBLE EVOLUTIONARY SIGNIFICANCE. Evolution; international journal of organic evolution, 37(2), 404-412. https://doi.org/10.1111/j.1558-5646.1983.tb05548.x
Slavkin, H C, et al. "ENAMEL-LIKE ANTIGENS IN HAGFISH: POSSIBLE EVOLUTIONARY SIGNIFICANCE." Evolution; international journal of organic evolution vol. 37,2 (1983): 404-412. doi: https://doi.org/10.1111/j.1558-5646.1983.tb05548.x
Slavkin HC, Graham E, Zeichner-David M, Hildemann W. ENAMEL-LIKE ANTIGENS IN HAGFISH: POSSIBLE EVOLUTIONARY SIGNIFICANCE. Evolution. 1983 Mar;37(2):404-412. doi: 10.1111/j.1558-5646.1983.tb05548.x. PMID: 28568376.
Copy Download .nbib Format: NLM
Combination of Complement-Dependent Cytotoxicity and Relative Fluorescent Quantification of HLA Length Polymorphisms Facilitates the Detection of a Loss of Heterozygosity.

Bone marrow research

Witter K, Reibke R, Subklewe M, Zahn R, Kauke T, Spiekermann K, Spannagl M, Tischer J, Hiddemann W, Dick A.
PMID: 24860670
Bone Marrow Res. 2014;2014:541345. doi: 10.1155/2014/541345. Epub 2014 Apr 03.

Loss of heterozygosity (LOH) is a common event in malignant cells. In this work we introduce a new approach to identify patients with loss of heterozygosity in the HLA region either at first diagnosis or after HLA mismatched allogeneic...

Cite
Witter K, Reibke R, Subklewe M, et al. Combination of Complement-Dependent Cytotoxicity and Relative Fluorescent Quantification of HLA Length Polymorphisms Facilitates the Detection of a Loss of Heterozygosity. Bone Marrow Res. 2014;2014:541345doi: 10.1155/2014/541345.
Witter, K., Reibke, R., Subklewe, M., Zahn, R., Kauke, T., Spiekermann, K., Spannagl, M., Tischer, J., Hiddemann, W., & Dick, A. (2014). Combination of Complement-Dependent Cytotoxicity and Relative Fluorescent Quantification of HLA Length Polymorphisms Facilitates the Detection of a Loss of Heterozygosity. Bone marrow research, 2014541345. https://doi.org/10.1155/2014/541345
Witter, Klaus, et al. "Combination of Complement-Dependent Cytotoxicity and Relative Fluorescent Quantification of HLA Length Polymorphisms Facilitates the Detection of a Loss of Heterozygosity." Bone marrow research vol. 2014 (2014): 541345. doi: https://doi.org/10.1155/2014/541345
Witter K, Reibke R, Subklewe M, Zahn R, Kauke T, Spiekermann K, Spannagl M, Tischer J, Hiddemann W, Dick A. Combination of Complement-Dependent Cytotoxicity and Relative Fluorescent Quantification of HLA Length Polymorphisms Facilitates the Detection of a Loss of Heterozygosity. Bone Marrow Res. 2014;2014:541345. doi: 10.1155/2014/541345. Epub 2014 Apr 03. PMID: 24860670; PMCID: PMC3996364.
Copy Download .nbib Format: NLM
Science instruction and religion.

Science (New York, N.Y.)

Hildemann WH.
PMID: 17808461
Science. 1982 Jun 04;216(4550):1048. doi: 10.1126/science.216.4550.1048.

No abstract available.

Cite
Hildemann WH. Science instruction and religion. Science. 1982;216(4550):1048doi: 10.1126/science.216.4550.1048.
Hildemann, W. H. (1982). Science instruction and religion. Science (New York, N.Y.), 216(4550), 1048. https://doi.org/10.1126/science.216.4550.1048
Hildemann, W H. "Science instruction and religion." Science (New York, N.Y.) vol. 216,4550 (1982): 1048. doi: https://doi.org/10.1126/science.216.4550.1048
Hildemann WH. Science instruction and religion. Science. 1982 Jun 04;216(4550):1048. doi: 10.1126/science.216.4550.1048. PMID: 17808461.
Copy Download .nbib Format: NLM
[Paraneoplastic syndromes].

Der Internist

Hiddemann W, Reincke M.
PMID: 29327270
Internist (Berl). 2018 Feb;59(2):113. doi: 10.1007/s00108-017-0374-1.

No abstract available.

Cite
Hiddemann W, Reincke M. Paraneoplastische Syndrome. [Paraneoplastic syndromes]. Internist (Berl). 2018;59(2):113doi: 10.1007/s00108-017-0374-1.
Hiddemann, W., & Reincke, M. (2018). Paraneoplastische Syndrome. [Paraneoplastic syndromes]. Der Internist, 59(2), 113. https://doi.org/10.1007/s00108-017-0374-1
Hiddemann, W, and Reincke, M. "Paraneoplastische Syndrome." [Paraneoplastic syndromes]. Der Internist vol. 59,2 (2018): 113. doi: https://doi.org/10.1007/s00108-017-0374-1
Hiddemann W, Reincke M. Paraneoplastische Syndrome. [Paraneoplastic syndromes]. Internist (Berl). 2018 Feb;59(2):113. doi: 10.1007/s00108-017-0374-1. German. PMID: 29327270.
Copy Download .nbib Format: NLM
Correction: Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk Prediction.

PloS one

Pohlen M, Thoennissen NH, Braess J, Thudium J, Schmid C, Kochanek M, Kreuzer KA, Lebiedz P, Görlich D, Gerth HU, Rohde C, Kessler T, Müller-Tidow C, Stelljes M, Hullerman C, Büchner T, Schlimok G, Hallek M, Waltenberger J, Hiddemann W, Berdel WE, Heilmeier B, Krug U.
PMID: 29293694
PLoS One. 2018 Jan 02;13(1):e0190802. doi: 10.1371/journal.pone.0190802. eCollection 2018.

[This corrects the article DOI: 10.1371/journal.pone.0160871.].

Cite
Pohlen M, Thoennissen NH, Braess J, et al. Correction: Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk Prediction. PLoS One. 2018;13(1):e0190802doi: 10.1371/journal.pone.0190802.
Pohlen, M., Thoennissen, N. H., Braess, J., Thudium, J., Schmid, C., Kochanek, M., Kreuzer, K. A., Lebiedz, P., Görlich, D., Gerth, H. U., Rohde, C., Kessler, T., Müller-Tidow, C., Stelljes, M., Hullerman, C., Büchner, T., Schlimok, G., Hallek, M., Waltenberger, J., Hiddemann, W., Berdel, W. E., Heilmeier, B., & Krug, U. (2018). Correction: Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk Prediction. PloS one, 13(1), e0190802. https://doi.org/10.1371/journal.pone.0190802
Pohlen, Michele, et al. "Correction: Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk Prediction." PloS one vol. 13,1 (2018): e0190802. doi: https://doi.org/10.1371/journal.pone.0190802
Pohlen M, Thoennissen NH, Braess J, Thudium J, Schmid C, Kochanek M, Kreuzer KA, Lebiedz P, Görlich D, Gerth HU, Rohde C, Kessler T, Müller-Tidow C, Stelljes M, Hullerman C, Büchner T, Schlimok G, Hallek M, Waltenberger J, Hiddemann W, Berdel WE, Heilmeier B, Krug U. Correction: Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk Prediction. PLoS One. 2018 Jan 02;13(1):e0190802. doi: 10.1371/journal.pone.0190802. eCollection 2018. PMID: 29293694; PMCID: PMC5749855.
Copy Download .nbib Format: NLM
Tailoring Nanoscale Morphology of Polymer:Fullerene Blends Using Electrostatic Field.

ACS applied materials & interfaces

Elshobaki M, Gebhardt R, Carr J, Lindemann W, Wang W, Grieser E, Venkatesan S, Ngo E, Bhattacharjee U, Strzalka J, Jiang Z, Qiao Q, Petrich J, Vaknin D, Chaudhary S.
PMID: 27982563
ACS Appl Mater Interfaces. 2017 Jan 25;9(3):2678-2685. doi: 10.1021/acsami.6b10870. Epub 2016 Dec 16.

To tailor the nanomorphology in polymer/fullerene blends, we study the effect of electrostatic field (E-field) on the solidification of poly(3-hexylthiophene-2, 5-diyl) (P3HT):[6,6]-phenyl-C61-butyric acid methyl ester (PC

Cite
Elshobaki M, Gebhardt R, Carr J, et al. Tailoring Nanoscale Morphology of Polymer:Fullerene Blends Using Electrostatic Field. ACS Appl Mater Interfaces. 2016;9(3):2678-2685doi: 10.1021/acsami.6b10870.
Elshobaki, M., Gebhardt, R., Carr, J., Lindemann, W., Wang, W., Grieser, E., Venkatesan, S., Ngo, E., Bhattacharjee, U., Strzalka, J., Jiang, Z., Qiao, Q., Petrich, J., Vaknin, D., & Chaudhary, S. (2017). Tailoring Nanoscale Morphology of Polymer:Fullerene Blends Using Electrostatic Field. ACS applied materials & interfaces, 9(3), 2678-2685. https://doi.org/10.1021/acsami.6b10870
Elshobaki, Moneim, et al. "Tailoring Nanoscale Morphology of Polymer:Fullerene Blends Using Electrostatic Field." ACS applied materials & interfaces vol. 9,3 (2017): 2678-2685. doi: https://doi.org/10.1021/acsami.6b10870
Elshobaki M, Gebhardt R, Carr J, Lindemann W, Wang W, Grieser E, Venkatesan S, Ngo E, Bhattacharjee U, Strzalka J, Jiang Z, Qiao Q, Petrich J, Vaknin D, Chaudhary S. Tailoring Nanoscale Morphology of Polymer:Fullerene Blends Using Electrostatic Field. ACS Appl Mater Interfaces. 2017 Jan 25;9(3):2678-2685. doi: 10.1021/acsami.6b10870. Epub 2016 Dec 16. PMID: 27982563.
Copy Download .nbib Format: NLM
[Internal emergency cases at the interface of outpatient and inpatient].

Der Internist

Buerke M, Hasenfuß G, Hiddemann W, Sieber CC.
PMID: 28828494
Internist (Berl). 2017 Sep;58(9):881-882. doi: 10.1007/s00108-017-0304-2.

No abstract available.

Cite
Buerke M, Hasenfuß G, Hiddemann W, et al. Internistische Notfälle an der Schnittstelle von ambulant und stationär. [Internal emergency cases at the interface of outpatient and inpatient]. Internist (Berl). 2017;58(9):881-882doi: 10.1007/s00108-017-0304-2.
Buerke, M., Hasenfuß, G., Hiddemann, W., & Sieber, C. C. (2017). Internistische Notfälle an der Schnittstelle von ambulant und stationär. [Internal emergency cases at the interface of outpatient and inpatient]. Der Internist, 58(9), 881-882. https://doi.org/10.1007/s00108-017-0304-2
Buerke, M, et al. "Internistische Notfälle an der Schnittstelle von ambulant und stationär." [Internal emergency cases at the interface of outpatient and inpatient]. Der Internist vol. 58,9 (2017): 881-882. doi: https://doi.org/10.1007/s00108-017-0304-2
Buerke M, Hasenfuß G, Hiddemann W, Sieber CC. Internistische Notfälle an der Schnittstelle von ambulant und stationär. [Internal emergency cases at the interface of outpatient and inpatient]. Internist (Berl). 2017 Sep;58(9):881-882. doi: 10.1007/s00108-017-0304-2. German. PMID: 28828494.
Copy Download .nbib Format: NLM
Clonal heterogeneity of .

Oncotarget

Schranz K, Hubmann M, Harin E, Vosberg S, Herold T, Metzeler KH, Rothenberg-Thurley M, Janke H, Bräundl K, Ksienzyk B, Batcha AMN, Schaaf S, Schneider S, Bohlander SK, Görlich D, Berdel WE, Wörmann BJ, Braess J, Krebs S, Hiddemann W, Mansmann U, Spiekermann K, Greif PA.
PMID: 30046393
Oncotarget. 2018 Jul 10;9(53):30128-30145. doi: 10.18632/oncotarget.25729. eCollection 2018 Jul 10.

In acute myeloid leukemia (AML), internal tandem duplications (ITDs) of

Cite
Schranz K, Hubmann M, Harin E, et al. Clonal heterogeneity of . Oncotarget. 2018;9(53):30128-30145doi: 10.18632/oncotarget.25729.
Schranz, K., Hubmann, M., Harin, E., Vosberg, S., Herold, T., Metzeler, K. H., Rothenberg-Thurley, M., Janke, H., Bräundl, K., Ksienzyk, B., Batcha, A. M. N., Schaaf, S., Schneider, S., Bohlander, S. K., Görlich, D., Berdel, W. E., Wörmann, B. J., Braess, J., Krebs, S., Hiddemann, W., Mansmann, U., Spiekermann, K., & Greif, P. A. (2018). Clonal heterogeneity of . Oncotarget, 9(53), 30128-30145. https://doi.org/10.18632/oncotarget.25729
Schranz, Katrin, et al. "Clonal heterogeneity of ." Oncotarget vol. 9,53 (2018): 30128-30145. doi: https://doi.org/10.18632/oncotarget.25729
Schranz K, Hubmann M, Harin E, Vosberg S, Herold T, Metzeler KH, Rothenberg-Thurley M, Janke H, Bräundl K, Ksienzyk B, Batcha AMN, Schaaf S, Schneider S, Bohlander SK, Görlich D, Berdel WE, Wörmann BJ, Braess J, Krebs S, Hiddemann W, Mansmann U, Spiekermann K, Greif PA. Clonal heterogeneity of . Oncotarget. 2018 Jul 10;9(53):30128-30145. doi: 10.18632/oncotarget.25729. eCollection 2018 Jul 10. PMID: 30046393; PMCID: PMC6059024.
Copy Download .nbib Format: NLM
Clinical and molecular relevance of genetic variants in the non-coding transcriptome of patients with cytogenetically normal acute myeloid leukemia.

Haematologica

Papaioannou D, Ozer HG, Nicolet D, Urs AP, Herold T, Mrózek K, Batcha AMN, Metzeler KH, Yilmaz AS, Volinia S, Bill M, Kohlschmidt J, Pietrzak M, Walker CJ, Carroll AJ, Braess J, Powell BL, Eisfeld AK, Uy GL, Wang ES, Kolitz JE, Stone RM, Hiddemann W, Byrd JC, Bloomfield CD, Garzon R.
PMID: 34261293
Haematologica. 2021 Jul 15; doi: 10.3324/haematol.2021.266643. Epub 2021 Jul 15.

Expression levels of long non-coding RNAs (lncRNAs) have been shown to associate with clinical outcome of patients with cytogenetically normal acute myeloid leukemia (CN-AML). However, the frequency and clinical significance of genetic variants in the nucleotide sequences of lncRNAs...

Cite
Papaioannou D, Ozer HG, Nicolet D, et al. Clinical and molecular relevance of genetic variants in the non-coding transcriptome of patients with cytogenetically normal acute myeloid leukemia. Haematologica. 2021;doi: 10.3324/haematol.2021.266643.
Papaioannou, D., Ozer, H. G., Nicolet, D., Urs, A. P., Herold, T., Mrózek, K., Batcha, A. M. N., Metzeler, K. H., Yilmaz, A. S., Volinia, S., Bill, M., Kohlschmidt, J., Pietrzak, M., Walker, C. J., Carroll, A. J., Braess, J., Powell, B. L., Eisfeld, A. K., Uy, G. L., Wang, E. S., Kolitz, J. E., Stone, R. M., Hiddemann, W., Byrd, J. C., Bloomfield, C. D., & Garzon, R. (2021). Clinical and molecular relevance of genetic variants in the non-coding transcriptome of patients with cytogenetically normal acute myeloid leukemia. Haematologica, . https://doi.org/10.3324/haematol.2021.266643
Papaioannou, Dimitrios, et al. "Clinical and molecular relevance of genetic variants in the non-coding transcriptome of patients with cytogenetically normal acute myeloid leukemia." Haematologica vol. (2021). doi: https://doi.org/10.3324/haematol.2021.266643
Papaioannou D, Ozer HG, Nicolet D, Urs AP, Herold T, Mrózek K, Batcha AMN, Metzeler KH, Yilmaz AS, Volinia S, Bill M, Kohlschmidt J, Pietrzak M, Walker CJ, Carroll AJ, Braess J, Powell BL, Eisfeld AK, Uy GL, Wang ES, Kolitz JE, Stone RM, Hiddemann W, Byrd JC, Bloomfield CD, Garzon R. Clinical and molecular relevance of genetic variants in the non-coding transcriptome of patients with cytogenetically normal acute myeloid leukemia. Haematologica. 2021 Jul 15; doi: 10.3324/haematol.2021.266643. Epub 2021 Jul 15. PMID: 34261293.
Copy Download .nbib Format: NLM
Validation of POD24 As a Robust Early Clinical Endpoint of Poor Survival in FL from 5,225 Patients on 13 Clinical Trials.

Blood

Casulo C, Dixon JG, Le-Rademacher J, Hoster E, Hochster H, Hiddemann W, Marcus RE, Kimby EK, Herold M, Sebban CJ, Gyan E, Foon KA, Nielsen TG, Vitolo U, Salles GA, Shi Q, Flowers CR.
PMID: 34614146
Blood. 2021 Oct 06; doi: 10.1182/blood.2020010263. Epub 2021 Oct 06.

Observational studies and standalone trials indicate that patients with follicular lymphoma (FL) who experience disease progression within 24 months of front-line chemoimmunotherapy (POD24), have poor outcomes. We performed a pooled analysis of 13 randomized clinical trials of FL patients...

Cite
Casulo C, Dixon JG, Le-Rademacher J, et al. Validation of POD24 As a Robust Early Clinical Endpoint of Poor Survival in FL from 5,225 Patients on 13 Clinical Trials. Blood. 2021;doi: 10.1182/blood.2020010263.
Casulo, C., Dixon, J. G., Le-Rademacher, J., Hoster, E., Hochster, H., Hiddemann, W., Marcus, R. E., Kimby, E. K., Herold, M., Sebban, C. J., Gyan, E., Foon, K. A., Nielsen, T. G., Vitolo, U., Salles, G. A., Shi, Q., & Flowers, C. R. (2021). Validation of POD24 As a Robust Early Clinical Endpoint of Poor Survival in FL from 5,225 Patients on 13 Clinical Trials. Blood, . https://doi.org/10.1182/blood.2020010263
Casulo, Carla, et al. "Validation of POD24 As a Robust Early Clinical Endpoint of Poor Survival in FL from 5,225 Patients on 13 Clinical Trials." Blood vol. (2021). doi: https://doi.org/10.1182/blood.2020010263
Casulo C, Dixon JG, Le-Rademacher J, Hoster E, Hochster H, Hiddemann W, Marcus RE, Kimby EK, Herold M, Sebban CJ, Gyan E, Foon KA, Nielsen TG, Vitolo U, Salles GA, Shi Q, Flowers CR. Validation of POD24 As a Robust Early Clinical Endpoint of Poor Survival in FL from 5,225 Patients on 13 Clinical Trials. Blood. 2021 Oct 06; doi: 10.1182/blood.2020010263. Epub 2021 Oct 06. PMID: 34614146.
Copy Download .nbib Format: NLM
Clinical and molecular relevance of genetic variants in the non-coding transcriptome of patients with cytogenetically normal acute myeloid leukemia.

Haematologica

Papaioannou D, Ozer HG, Nicolet D, Urs AP, Herold T, Mrózek K, Batcha AMN, Metzeler KH, Yilmaz AS, Volinia S, Bill M, Kohlschmidt J, Pietrzak M, Walker CJ, Carroll AJ, Braess J, Powell BL, Eisfeld AK, Uy GL, Wang ES, Kolitz JE, Stone RM, Hiddemann W, Byrd JC, Bloomfield CD, Garzon R.
PMID: 34261293
Haematologica. 2021 Jul 15; doi: 10.3324/haematol.2021.266643. Epub 2021 Jul 15.

Expression levels of long non-coding RNAs (lncRNAs) have been shown to associate with clinical outcome of patients with cytogenetically normal acute myeloid leukemia (CN-AML). However, the frequency and clinical significance of genetic variants in the nucleotide sequences of lncRNAs...

Cite
Papaioannou D, Ozer HG, Nicolet D, et al. Clinical and molecular relevance of genetic variants in the non-coding transcriptome of patients with cytogenetically normal acute myeloid leukemia. Haematologica. 2021;doi: 10.3324/haematol.2021.266643.
Papaioannou, D., Ozer, H. G., Nicolet, D., Urs, A. P., Herold, T., Mrózek, K., Batcha, A. M. N., Metzeler, K. H., Yilmaz, A. S., Volinia, S., Bill, M., Kohlschmidt, J., Pietrzak, M., Walker, C. J., Carroll, A. J., Braess, J., Powell, B. L., Eisfeld, A. K., Uy, G. L., Wang, E. S., Kolitz, J. E., Stone, R. M., Hiddemann, W., Byrd, J. C., Bloomfield, C. D., & Garzon, R. (2021). Clinical and molecular relevance of genetic variants in the non-coding transcriptome of patients with cytogenetically normal acute myeloid leukemia. Haematologica, . https://doi.org/10.3324/haematol.2021.266643
Papaioannou, Dimitrios, et al. "Clinical and molecular relevance of genetic variants in the non-coding transcriptome of patients with cytogenetically normal acute myeloid leukemia." Haematologica vol. (2021). doi: https://doi.org/10.3324/haematol.2021.266643
Papaioannou D, Ozer HG, Nicolet D, Urs AP, Herold T, Mrózek K, Batcha AMN, Metzeler KH, Yilmaz AS, Volinia S, Bill M, Kohlschmidt J, Pietrzak M, Walker CJ, Carroll AJ, Braess J, Powell BL, Eisfeld AK, Uy GL, Wang ES, Kolitz JE, Stone RM, Hiddemann W, Byrd JC, Bloomfield CD, Garzon R. Clinical and molecular relevance of genetic variants in the non-coding transcriptome of patients with cytogenetically normal acute myeloid leukemia. Haematologica. 2021 Jul 15; doi: 10.3324/haematol.2021.266643. Epub 2021 Jul 15. PMID: 34261293.
Copy Download .nbib Format: NLM
Analysis of the osseous/metal interface of drill free screws and self-tapping screws.

Journal of maxillofacial surgery

Heidemann W, Terheyden H, Louis Gerlach K.
PMID: 11308282
J Maxillofac Surg. 2001 Apr;29(2):69-74. doi: 10.1054/jcms.2000.0179.

Aim: A comparison of metal/osseous interface and bone remodelling after insertion of different types of titanium bone screws in vivo. Material: Samples of five of each of the following bone screw types were inserted into the anterior wall of...

Cite
Heidemann W, Terheyden H, Louis Gerlach K. Analysis of the osseous/metal interface of drill free screws and self-tapping screws. J Maxillofac Surg. 2001;29(2):69-74doi: 10.1054/jcms.2000.0179.
Heidemann, W., Terheyden, H., & Louis Gerlach, K. (2001). Analysis of the osseous/metal interface of drill free screws and self-tapping screws. Journal of maxillofacial surgery, 29(2), 69-74. https://doi.org/10.1054/jcms.2000.0179
Heidemann, Wolfgang, et al. "Analysis of the osseous/metal interface of drill free screws and self-tapping screws." Journal of maxillofacial surgery vol. 29,2 (2001): 69-74. doi: https://doi.org/10.1054/jcms.2000.0179
Heidemann W, Terheyden H, Louis Gerlach K. Analysis of the osseous/metal interface of drill free screws and self-tapping screws. J Maxillofac Surg. 2001 Apr;29(2):69-74. doi: 10.1054/jcms.2000.0179. PMID: 11308282.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 44 entries